×
About 9,653 results

ALLMedicine™ Deep Vein Thrombosis Center

Research & Reviews  3,192 results

Anticoagulants for acute ischaemic stroke.
https://doi.org/10.1002/14651858.CD000024.pub5
The Cochrane Database of Systematic Reviews; Wang X, Ouyang M et. al.

Oct 23rd, 2021 - Stroke is the third leading cause of early death worldwide. Most ischaemic strokes are caused by a blood clot blocking an artery in the brain. Patient outcomes might be improved if they are offered anticoagulants that reduce their risk of developi...

Complications from ankle arthrodesis in diabetes-related Charcot foot syndrome.
https://doi.org/10.1016/j.jdiacomp.2021.108071
Journal of Diabetes and Its Complications; Wang BK, Wukich DK et. al.

Oct 23rd, 2021 - Charcot neuroarthropathy (CN) is an inflammatory arthropathy associated with bony destruction, dislocation, and deformity in patients with neuropathy. Surgical procedures involving foot and ankle in CN for deformity correction have been shown to r...

A Study Related to the VOYAGER PAD Trial to Learn More About the Target Population for Xarelto in French Patients
https://clinicaltrials.gov/ct2/show/NCT04824729

Oct 22nd, 2021 - This is a study to learn more about French patients who have peripheral artery disease (PAD) and who have had a revascularization procedure. With this procedure, doctors use surgery or a thin tube (called a catheter) to open a narrow or blocked bl...

Diagnostic performance of Caprini risk assessment model combined with D-dimer for preop...
https://doi.org/10.1016/j.wneu.2021.10.106
World Neurosurgery; Wang H, Lv B et. al.

Oct 22nd, 2021 - To assess the validity of Caprini risk assessment model(RAM) in risk stratification for deep vein thrombosis (DVT) and to investigate the diagnostic value of Caprini score combined with D-dimer in predicting DVT. This study involved 429 patients w...

Effect of Moderate vs Mild Therapeutic Hypothermia on Mortality and Neurologic Outcomes...
https://doi.org/10.1001/jama.2021.15703
JAMA Le May M, Osborne C et. al.

Oct 20th, 2021 - Comatose survivors of out-of-hospital cardiac arrest experience high rates of death and severe neurologic injury. Current guidelines recommend targeted temperature management at 32 °C to 36 °C for 24 hours. However, small studies suggest a potenti...

see more →

Guidelines  12 results

American Society of Hematology 2020 guidelines for management of venous thromboembolism...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556153
Blood Advances; Ortel TL, Neumann I et. al.

Oct 3rd, 2020 - Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), occurs in ∼1 to 2 individuals per 1000 each year, corresponding to ∼300 000 to 600 000 events in the United States annually. These evidence-based ...

ACR Appropriateness Criteria® Suspected Upper Extremity Deep Vein Thrombosis.
https://doi.org/10.1016/j.jacr.2020.01.020
Journal of the American College of Radiology : JACR; , Desjardins B et. al.

May 7th, 2020 - This publication includes the appropriate imaging modalities to assess suspected deep vein thrombosis in the upper extremities. Ultrasound duplex Doppler is the most appropriate imaging modality to assess upper-extremity deep vein thrombosis. It i...

ACR Appropriateness Criteria® Radiologic Management of Iliofemoral Venous Thrombosis.
https://doi.org/10.1016/j.jacr.2020.01.035
Journal of the American College of Radiology : JACR; , Farsad K et. al.

May 7th, 2020 - Iliofemoral venous thrombosis carries a high risk for pulmonary embolism, recurrent deep vein thrombosis, and post-thrombotic syndrome complicating 30% to 71% of those affected. The clinical scenarios in which iliofemoral venous thrombosis is mana...

ACR Appropriateness Criteria® Radiologic Management of Venous Thromboembolism-Inferior ...
https://doi.org/10.1016/j.jacr.2019.02.010
Journal of the American College of Radiology : JACR; , Minocha J et. al.

May 6th, 2019 - Venous thromboembolism (VTE)-deep vein thrombosis and pulmonary embolism-is a common cause of morbidity and mortality. The mainstay of VTE prophylaxis and therapy is anticoagulation. In select patients with VTE, inferior vena cava (IVC) filters ar...

ACR Appropriateness Criteria® Suspected Lower Extremity Deep Vein Thrombosis.
https://doi.org/10.1016/j.jacr.2018.09.028
Journal of the American College of Radiology : JACR; , Hanley M et. al.

Nov 6th, 2018 - Suspected lower extremity deep venous thrombosis is a common clinical scenario which providers seek a reliable test to guide management. The importance of confidently making this diagnosis lies in the 50% to 60% risk of pulmonary embolism with unt...

see more →

Drugs  68 results see all →

Clinicaltrials.gov  80 results

A Study Related to the VOYAGER PAD Trial to Learn More About the Target Population for Xarelto in French Patients
https://clinicaltrials.gov/ct2/show/NCT04824729

Oct 22nd, 2021 - This is a study to learn more about French patients who have peripheral artery disease (PAD) and who have had a revascularization procedure. With this procedure, doctors use surgery or a thin tube (called a catheter) to open a narrow or blocked bl...

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
https://clinicaltrials.gov/ct2/show/NCT03395639

Oct 15th, 2021 - The primary objective is to compare the safety of edoxaban with the standard of care (SOC) in pediatric subjects with cardiac diseases at risk of thromboembolic complications who need primary or secondary anticoagulant prophylaxis with regard to t...

The Effects of Bed Exercises on Anxiety, Pain, Early Ambulation and Mobilization in Patients Undergoing Major Surgery
https://clinicaltrials.gov/ct2/show/NCT05057585

Oct 11th, 2021 - Major surgery is a serious physiological condition that can cause significant morbidity and mortality. Adverse conditions encountered during major surgery may be fatal, cause one or more postoperative complications, negatively affect short-term an...

Prevalence and Risk Factors of Chronic Thrombo-embolic Disease After a Pulmonary Embolism Event
https://clinicaltrials.gov/ct2/show/NCT05073666

Oct 11th, 2021 - Venous thromboembolic disease (VTE) is a common clinical entity whose two manifestations are deep vein thrombosis (DVT) and pulmonary embolism (PE). After an acute PE, almost half of the patients complain residual dyspnea, despite well-conducted c...

Unleash the Mystery of COVID-19 Related Unusual Thrombosis
https://clinicaltrials.gov/ct2/show/NCT05068375

Oct 11th, 2021 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in Wuhan, China in December of 2019, has become a worldwide pandemic with widespread illness and mortality. Clinical manifestations of Coronavirus disease 2019 (COVID-1...

see more →

News  504 results

Direct Oral Anticoagulants Signal Change in VTE Prevention
https://www.onclive.com/view/direct-oral-anticoagulants-signal-change-in-vte-prevention

Oct 6th, 2021 - Alok A. Khorana, MD Investigators at Cleveland Clinic have demonstrated that the direct oral anticoagulant rivaroxaban (Xarelto) significantly reduces venous thromboembolism (VTE) and VTE-related death for patients with high-risk cancers treated ...

Oral Anticoagulants Demonstrate Value in Management of Acute VTE
https://www.onclive.com/view/oral-anticoagulants-demonstrate-value-in-management-of-acute-vte

Oct 6th, 2021 - Katherine C. Rappazzo, MD Jennifer R. Green, MD Assistant Professor of Medicine, Director of the Vanderbilt Hemophilia/ Hemostasis Treatment Clinic, Vanderbilt University Medical Center, Nashville, Tennessee In the treatment of acut...

Advances in the Management of Hepatic and Pancreatic Malignancies
https://www.onclive.com/view/advances-in-the-management-of-hepatic-and-pancreatic-malignancies

Oct 6th, 2021 - Perry Shen, MD, FACS Clancy Clark, MD Wake Forest Baptist Health Comprehensive Cancer Center Despite an overall decline in cancer death rates during the last decade, hepatic and pancreatic cancer death rates are on ...

PEGPH20 Combination Doubles PFS in HA-High Pancreatic Cancer
https://www.onclive.com/view/pegph20-combination-doubles-pfs-in-ha-high-pancreatic-cancer

Oct 6th, 2021 - Sunil R. Hingorani, MD, PhD The addition of the enzyme PEGPH20 to standard nab-paclitaxel and gemcitabine improved progression-free survival (PFS) by 4.9 months compared with the two agents alone in untreated patients with advanced pancreatic can...

CAR-T Progress Continues in Non-Hodgkin Lymphoma, But Guidelines Need Updating
https://www.onclive.com/view/cart-progress-continues-in-nonhodgkin-lymphoma-but-guidelines-need-updating

Oct 6th, 2021 - Miguel Perales, MD CAR T-cell therapy has emerged as a promising therapy for select patients with non-Hodgkin lymphoma (NHL), but as research continues and the treatment is used in a real-world setting, overarching guidelines must be set in place...

see more →

Patient Education  5 results see all →